Norway, April 27 -- ArcticZymes Technologies announced its participation as an associated partner in the CAARE (Consortium for Advanced Analytical and Recovery Engineering) project, alongside an expansion of its ongoing research collaboration with the Austrian Centre of Industrial Biotechnology (acib), supported by additional funding through the COMET program.Together, these developments reinforce ArcticZymes' commitment to advancing downstream processing solutions for bionanoparticles, including viral vectors used in gene therapy, vaccines, and oncology applications. Demand for viral vector manufacturing solutions continues to increase, driven by growth in gene therapy and next-generation cell therapy platforms.The collaboration with acib ...